Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID-MANAGE: Personalized Anti-Platelet Therapy in ACS
NCT02044146Phase 3Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Sep 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prasugrel in acute coronary syndrome (ACS), sponsored by University of Ottawa Heart Institute. Started Sep 2014; status: completed.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02044146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044146.